SCHEMBL18790198

SCHEMBL18790198

Cc1cc(Cl)ccc1C(=O)N1CCCC(C(=O)Nc2cccc(C(C)(C)C)c2)C1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ AVPR2 P30518 2/20 0.41
▸ AVPR1A P37288 2/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ ADRB2 P07550 1/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ TBXA2R P21731 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HRH1 P35367 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ GLP1R P43220 1/20 0.41
▸ TMEM97 Q5BJF2 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ GPR119 Q8TDV5 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14959050 1.00 P2RX1 (0.43) P2RX1RXFP1ALDH1A1AVPR2AVPR1A
SCHEMBL13059322 1.00 P2RX1 (0.43) P2RX1RXFP1ALDH1A1AVPR2AVPR1A
SCHEMBL12176053 0.93 PREP (0.42) P2RX1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL18609269 0.92 ALDH1A1 (0.46) RXFP1ALDH1A1NR1H4ACKR3TSHR
SCHEMBL13059992 0.92 ALDH1A1 (0.46) RXFP1ALDH1A1NR1H4ACKR3TSHR
SCHEMBL18789915 0.92 ALDH1A1 (0.46) RXFP1ALDH1A1NR1H4ACKR3TSHR
SCHEMBL14959054 0.92 ALDH1A1 (0.46) RXFP1ALDH1A1NR1H4ACKR3TSHR
SCHEMBL24016857 0.91 HSD17B10 (0.46) RXFP1ALDH1A1TSHR
SCHEMBL18609695 0.91 HSD17B10 (0.46) RXFP1ALDH1A1TSHR
SCHEMBL14959019 0.91 HSD17B10 (0.46) RXFP1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4015504-A1 C5AR ANTAGONISTS ChemoCentryx, Inc. (US) 2022-06-22 — — EP disclosed
EP-3508477-B1 C5AR ANTAGONISTS CHEMOCENTRYX INC (US) 2021-11-10 — — EP disclosed
EP-3508477-A1 C5AR ANTAGONISTS ChemoCentryx, Inc. (US) 2019-07-10 — — EP disclosed
US-20170114017-A1 C5AR ANTAGONISTS CHEMOCENTRYX, INC. 2017-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114017-A1 C5AR ANTAGONISTS C5AR1, C5AR2, C3AR1 P2RX1 112/4885RXFP1 911/4885ALDH1A1 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback